Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

long-term condition

High staff turnover found in CROs

US research firm warns that pharma companies will assess CRO turnover rates

- PMLiVE

FDA approves return of morning sickness drug for pregnant women

Regulator confirms safety of Diclegis – formerly known as Bendectin

- PMLiVE

Tamiflu sales boost Roche results despite efficacy concerns

Pharma company reports total sales of $12.44bn in first quarter of 2013

- PMLiVE

First efficacy data for GSK/Prosensa’s muscular dystrophy candidate positive

Ups ante in race against Sarepta Therapeutics to market first Duchenne muscular dystrophy drug

- PMLiVE

PAN promotes Julia Straker to board of directors

Becomes director of strategic brand planning

Coulter Partners expands North American team

Madeline Barrett and Nancy McCloskey join New Jersey office

- PMLiVE

Additional NICE recommendation for Novartis’ Lucentis

Says drug can be used in patients with macular oedema caused by blockage of the veins in the retina

- PMLiVE

US-based Millennium launches blood cancer website

The Takeda Oncology Company roll out new multiple myeloma website

- PMLiVE

3 Monkeys launch healthcare practice

Agency hires Dr Martin Godfrey to lead the new division

- PMLiVE

Clinical trials for EMA-submitted medicines move away from US and Europe

Most trial patients for drug marketing applications to EMA now come from rest of the world

- PMLiVE

Gilead files oral hepatitis C drug sofosbuvir in US

Could be part of first all-oral regimen for virus

- PMLiVE

Alkermes cuts jobs in Ireland as Novartis invests

130 jobs to go at manufacturing facility in Athlone as Novartis creates 100 roles in Dublin

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links